Intermittent hypoxia and behavior: Is dopamine to blame?

Sleep

Volumn 28, Issue 2, 2005, Pages 165-167

  Row, Barry W ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ATTENTION DEFICIT DISORDER; BEHAVIOR; CATECHOLAMINERGIC SYSTEM; DOPAMINE RELEASE; EDITORIAL; HUMAN; HYPOXIA; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME;

ANIMALS; ANOXIA; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; GLUTAMIC ACID; HIPPOCAMPUS; LOCOMOTION; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; PHENOTYPE; RATS;

EID: 14944353543     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (41)

1. Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 1997;20(12):1185-92.
2. Gottlieb DJ, Vezina RM, Chase C, Lesko SM, Heeren TC, Weese-Mayer DE, et al. Symptoms of sleep-disordered breathing in 5-year-old children are associated with sleepiness and problem behaviors. Pediatrics 2003;112(4):870-7.
3. Gozal D, Daniel JM, Dohanich GP. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci 2001;21(7):2442-50.
4. Row BW, Kheirandish L, Neville JJ, Gozal D. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002;52(3):449-53.
5. Veasey SC, Zhan G, Fenik P, Pratico D. Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output. Am J Respir Crit Care Med 2004;170(6):665-72.
6. Biederman J, Faraone SV. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder. J Atten Disord 2002;6 Suppl 1:S7-16.
7. Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB. Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling. Neuroscience 2003;117(2):417-25.
8. Nyakas C, Markel E, Schuurman T, Luiten PG. Impaired Learning and Abnormal Open-field Behaviours of Rats After Early Postnatal Anoxia and the Beneficial Effect of the Calcium Antagonist Nimodipine. Eur J Neurosci 1991;3(2):168-174.
9. Nyakas C, Buwalda B, Kramers RJ, Traber J, Luiten PG. Postnatal development of hippocampal and neocortical cholinergic and serotonergic innervation in rat: effects of nitrite-induced prenatal hypoxia and nimodipine treatment. Neuroscience 1994;59(3):541-59.
10. Nyakas C, Buwalda B, Luiten PG. Hypoxia and brain development. Prog Neurobiol 1996;49(1):1-51.
11. Li RC, Row BW, Gozal E, Kheirandish L, Fan Q, Brittian KR, et al. Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. Am J Respir Crit Care Med 2003;168(4):469-75.
12. Gozal E, Row BW, Schurr A, Gozal D. Developmental differences in cortical and hippocampal vulnerability to intermittent hypoxia in the rat. Neurosci Lett 2001;305(3):197-201.
13. Vannucci RC, Rossini A, Towfighi J, Vannucci SJ. Measuring the accentuation of the brain damage that arises from perinatal cerebral hypoxia-ischemia. Biol Neonate 1997;72(3):187-91.
14. Towfighi J, Mauger D, Vannucci RC, Vannucci SJ. Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res 1997;100(2):149-60.
15. Nishino H, Hida H, Kumazaki M, Shimano Y, Nakajima K, Shimizu H, et al. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J Neurotrauma 2000;17(3):251-60.
16. El-Khodor BF, Flores G, Srivastava LK, Boksa P. Effects of birth insult and stress at adulthood on excitatory amino acid receptors in adult rat brain. Synapse 2004;54(3):138-46.
17. Grace AA, Moore H, O'Donnell P. The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia. Adv Pharmacol 1998;42:721-4.
18. Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 2003;6(9):968-73.
19. Russell VA. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-the spontaneously hypertensive rat. Neurosci Biobehav Rev 2003;27(7):671-82.
20. Lanau F, Zenner MT, Civelli O, Hartman DS. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 1997;68(2):804-12.
21. Newman-Tancredi A, Audinot-Bouchez V, Gobert A, Millan MJ. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur J Pharmacol 1997;319(2-3):379-83.
22. Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 2003;42(1):1-21.
23. Offen D, Hochman A, Gorodin S, Ziv I, Shirvan A, Barzilai A, et al. Oxidative stress and neuroprotection in Parkinson's disease: implications from studies on dopamine-induced apoptosis. Adv Neurol 1999;80:265-9.
24. Rabinovic AD, Lewis DA, Hastings TG. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 2000;101(1):67-76.
25. Shin Y, White BH, Uh M, Sidhu A. Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation. Brain Res 2003;968(1):102-13.
26. Shaywitz BA, Yager RD, Klopper JH. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 1976;191(4224):305-8.
27. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 2001;292(5526):2499-501.
28. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379(6566):606-12.
29. Viggiano D, Grammatikopoulos G, Sadile AG. A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav Brain Res 2002;130(1-2):181-9.
30. Arnsten AF. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997;11(2):151-62.
31. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121(1):65-94.
32. Durston S. A review of the biological bases of ADHD: what have we learned from imaging studies? Ment Retard Dev Disabil Res Rev 2003;9(3):184-95.
33. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998;44(10):951-8.
34. Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002;11(1):1-16.
35. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002;3(8):617-28.
36. Castellanos FX. Neural substrates of attention-deficit hyperactivity disorder. Adv Neurol 2001;85:197-206.
37. Russell VA. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Behav Brain Res 2002;130(1-2):191-6.
38. Altman J. Morphological and behavioral markers of environmentally induced retardation of brain development: an animal model. Environ Health Perspect 1987;74:153-68.
39. Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan GD, Wigal T, et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 2001;29(3):215-28.
40. Solanto MV. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 2002;130(1-2):65-71.
41. Thierry AM, Gioanni Y, Degenetais E, Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 2000;10(4):411-9.